Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "As the Nifty is a little unsure, largecaps are best avoided. But the bigger point is that even as the markets now give a sense that they will be in a range for two days, there is no break down on charts. The charts, whether it is for largecaps or midcaps are not telling us that distribution is taking place. Now, markets can do anything, but that is interesting. So, the idea is to go any buy midcaps.""Aurobindo Pharma, Havells India and LIC Housing Finance have given mild corrections after run-ups. I always like to buy these mild dips because you are then positioned well with better risk reward. So, the three stocks for buying are midcaps with mild correction and strong uptrends," he said.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!